Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 26 May 2023

The macrophage infectivity potentiator of Trypanosoma cruzi induces innate IFN-γ and TNF-α production by human neonatal and adult blood cells through TLR2/1 and TLR4

in Vaccines and Molecular Therapeutics

Sarra Ait Djebbara
Saria Mcheik
Pauline Percier
Noria Segueni
Antoine Poncelet
Carine Truyens

Frontiers in Immunology

doi 10.3389/fimmu.2023.1180900

3,090 views
5 citations

Original Research

Published on 25 May 2023

Low-dose radiation therapy suppresses viral pneumonia by enhancing broad-spectrum anti-inflammatory responses via transforming growth factor-β production

in Vaccines and Molecular Therapeutics

Ha-Yeon Song
Fengjia Chen
Hae Ran Park
Jeong Moo Han
Hyun Jung Ji
Eui-Baek Byun
Yeongkag Kwon
Min-Kyu Kim
Ki Bum Ahn
Ho Seong Seo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1182927

3,323 views
3 citations

Original Research

Published on 25 May 2023

Sex-dependent differences in behavioral and immunological responses to antibiotic and bacteriophage administration in mice

in Vaccines and Molecular Therapeutics

Łukasz Grabowski
Karolina Pierzynowska
Katarzyna Kosznik-Kwaśnicka
Małgorzata Stasiłojć
Grażyna Jerzemowska
Alicja Węgrzyn
Grzegorz Węgrzyn
Magdalena Podlacha

Frontiers in Immunology

doi 10.3389/fimmu.2023.1133358

3,699 views
8 citations

Original Research

Published on 25 May 2023

Reducedhumoral response against variants of concern in childhood solid cancer patients compared to adult patients and healthy children after SARS-CoV-2 vaccination

in Vaccines and Molecular Therapeutics

Yifei Ma
Bocen Chen
Yanqi Wang
Pengfei Zhu
Nianqi Liu
Zhiying Zhang
Guanqing Zhong
Guangzhen Fu
Dao Wang
Lu Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1110755

3,056 views
3 citations

Original Research

Published on 24 May 2023

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern

in Vaccines and Molecular Therapeutics

Qinhai Ma
Man Li
Lin Ma
Caroline Zhang
Hong Zhang
Huiling Zhong
Jian Wen
Yongsheng Wang
Zewei Yan
Wei Xiong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1195299

5,915 views
8 citations

Correction

Published on 24 May 2023

Corrigendum: The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections

in Vaccines and Molecular Therapeutics

Konstantin Föhse
Esther J. M. Taks
Simone J. C. F. M. Moorlag
Marc J. M. Bonten
Reinout van Crevel
Jaap ten Oever
Cornelis H. van Werkhoven
Mihai G. Netea
Josephine S. van de Maat
Jacobien J. Hoogerwerf

Frontiers in Immunology

doi 10.3389/fimmu.2023.1208659

1,322 views

Opinion

Published on 23 May 2023

Two issues should be noted when designing a clinical trial to evaluate BCG effects on COVID-19

in Vaccines and Molecular Therapeutics

Wenping Gong
Yinping Liu
Yong Xue
Li Zhuang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1207212

1,512 views
6 citations

Review

Published on 23 May 2023

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

in Vaccines and Molecular Therapeutics

Shanti Pather
Shabir A. Madhi
Benjamin J. Cowling
Paul Moss
Jeremy P. Kamil
Sandra Ciesek
Alexander Muik
Özlem Türeci

Frontiers in Immunology

doi 10.3389/fimmu.2023.1130539

9,522 views
58 citations

Original Research

Published on 22 May 2023

High immunogenicity of virus-like particles (VLPs) decorated with Aeromonas salmonicida VapA antigen in rainbow trout

in Vaccines and Molecular Therapeutics

Jeong In Yang
Dagoberto Sepúlveda
Irina Vardia
Jakob Skov
Louise Goksøyr
Adam F. Sander
Niels Lorenzen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139206

5,105 views
4 citations

Brief Research Report

Published on 19 May 2023

Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization

in Vaccines and Molecular Therapeutics

Jeein Oh
Uni Park
Juhyung Kim
Kyeongseok Jeon
Chulwoo Kim
Nam-Hyuk Cho
Youn Soo Choi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1201136

2,837 views
1 citation

Original Research

Published on 19 May 2023

A tetravalent nanoparticle vaccine elicits a balanced and potent immune response against dengue viruses without inducing antibody-dependent enhancement

in Vaccines and Molecular Therapeutics

Qier Chen
Rong Li
Bolin Wu
Xu Zhang
Hui Zhang
Ran Chen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1193175

5,855 views
11 citations

Original Research

Published on 18 May 2023

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization

in Vaccines and Molecular Therapeutics

Kacy S. Yount
Jesse M. Hall
Kyle Caution
Mohamed M. Shamseldin
Myra Guo
Keirsten Marion
Audra R. Fullen
Yimin Huang
Jennifer A. Maynard
Sally A. Quataert

Frontiers in Immunology

doi 10.3389/fimmu.2023.1181876

4,545 views
10 citations

Original Research

Published on 18 May 2023

Production of monoclonal antibody of heat-labile toxin A subunit to identify enterotoxigenic Escherichia coli by epitope mapping using synthetic peptides

in Vaccines and Molecular Therapeutics

Jun-Young Park
Seung-Hak Cho

Frontiers in Immunology

doi 10.3389/fimmu.2023.1152910

2,242 views
1 citation

Original Research

Published on 17 May 2023

Antibody response and safety of inactivated SARS-CoV-2 vaccines in chronic hepatitis B patients with and without cirrhosis

in Vaccines and Molecular Therapeutics

Huanhuan Cao
Yufei Huang
Chunxiu Zhong
Xingmei Liao
Wenjuan Tan
Siru Zhao
Liangxu Guo
Rong Fan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1167533

2,390 views
3 citations

Original Research

Published on 17 May 2023

Analysis and comparison of SARS-CoV-2 variant antibodies and neutralizing activity for 6 months after a booster mRNA vaccine in a healthcare worker population

in Vaccines and Molecular Therapeutics

Sina Hosseinian
Rafael de Assis
Ghali Khalil
Madeleine K. Luu
Aarti Jain
Peter Horvath
Rie Nakajima
Anton M. Palma
Anthony Hoang
Eisa Razzak

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166261

2,202 views
8 citations

Review

Published on 15 May 2023

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

in Vaccines and Molecular Therapeutics

Susanna Esposito
Gayatri Amirthalingam
Matteo Bassetti
Francesco Blasi
Francesco Giuseppe De Rosa
Natasha B. Halasa
Ivan Hung
Albert Osterhaus
Tina Tan
Juan Pablo Torres

Frontiers in Immunology

doi 10.3389/fimmu.2023.1162342

12,730 views
19 citations